Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.
Clin Cancer Res. 2024 Feb 16;30(4):741-753. doi: 10.1158/1078-0432.CCR-23-2959.
Clin Cancer Res. 2024.
PMID: 38051741
Clinical Trial.
Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium.
Pasqualini C, Rubino J, Brard C, Cassard L, André N, Rondof W, Scoazec JY, Marchais A, Nebchi S, Boselli L, Grivel J, Aerts I, Thebaud E, Paoletti X, Minard-Colin V, Vassal G, Geoerger B.
Pasqualini C, et al. Among authors: rondof w.
Eur J Cancer. 2021 Jun;150:53-62. doi: 10.1016/j.ejca.2021.03.032. Epub 2021 Apr 20.
Eur J Cancer. 2021.
PMID: 33892407
Clinical Trial.
Item in Clipboard
Discovery of New Fusion Transcripts in a Cohort of Pediatric Solid Cancers at Relapse and Relevance for Personalized Medicine.
Dupain C, Harttrampf AC, Boursin Y, Lebeurrier M, Rondof W, Robert-Siegwald G, Khoueiry P, Geoerger B, Massaad-Massade L.
Dupain C, et al. Among authors: rondof w.
Mol Ther. 2019 Jan 2;27(1):200-218. doi: 10.1016/j.ymthe.2018.10.022. Epub 2018 Nov 2.
Mol Ther. 2019.
PMID: 30509566
Free PMC article.
Item in Clipboard
Genomic classification of benign adrenocortical lesions.
Faillot S, Foulonneau T, Néou M, Espiard S, Garinet S, Vaczlavik A, Jouinot A, Rondof W, Septier A, Drougat L, Hécale-Perlemoine K, Ragazzon B, Rizk-Rabin M, Sibony M, Bonnet-Serrano F, Guibourdenche J, Libé R, Groussin L, Dousset B, de Reyniès A, Bertherat J, Assié G.
Faillot S, et al. Among authors: rondof w.
Endocr Relat Cancer. 2021 Jan;28(1):79-95. doi: 10.1530/ERC-20-0128.
Endocr Relat Cancer. 2021.
PMID: 33151900
Item in Clipboard
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
Rich J, Bennaroch M, Notel L, Patalakh P, Alberola J, Issa F, Opolon P, Bawa O, Rondof W, Marchais A, Dessen P, Meurice G, Le-Gall M, Polrot M, Ser-Le Roux K, Mamchaoui K, Droin N, Raslova H, Maire P, Geoerger B, Pirozhkova I.
Rich J, et al. Among authors: rondof w.
EMBO Mol Med. 2024 Aug;16(8):1840-1885. doi: 10.1038/s44321-024-00097-z. Epub 2024 Jul 15.
EMBO Mol Med. 2024.
PMID: 39009887
Free PMC article.
Item in Clipboard
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers.
Lim WC, Marques Da Costa ME, Godefroy K, Jacquet E, Gragert L, Rondof W, Marchais A, Nhiri N, Dalfovo D, Viard M, Labaied N, Khan AM, Dessen P, Romanel A, Pasqualini C, Schleiermacher G, Carrington M, Zitvogel L, Scoazec JY, Geoerger B, Salmon J.
Lim WC, et al. Among authors: rondof w.
Front Immunol. 2024 Jan 22;14:1265469. doi: 10.3389/fimmu.2023.1265469. eCollection 2023.
Front Immunol. 2024.
PMID: 38318504
Free PMC article.
Item in Clipboard
Cite
Cite